Rekvina Laboratories' independent directors found the ₹10 open offer price fair, but noted it's significantly lower than the ₹37.45 market price. Investors should weigh this gap when deciding on the offer.
Rekvina Laboratories Open Offer: Fair Price, Higher Market Value
Rekvina Laboratories Limited's Independent Directors' Committee (IDC) has stated that the open offer price of ₹10 per equity share is fair and reasonable. The offer, made by acquirers Surbhit Mukesh Shah, Amit Mukesh Shah, and Dhruvalkumar Patel, involves 28,90,100 equity shares, totaling ₹2.89 crore.
Reader Takeaway: Fair offer price acknowledged; significant discount to market price poses investor dilemma.
What just happened
The Committee of Independent Directors (IDC) of Rekvina Laboratories Limited has reviewed an open offer for the company's shares. The acquirers are offering to buy 28,90,100 equity shares at ₹10 per share. The IDC, after considering valuation reports, has opined that the offer price is fair and reasonable as per SEBI (SAST) Regulations.
Why this matters
This development is crucial for existing shareholders as it provides an independent assessment of the open offer. While the IDC's opinion is a regulatory requirement, the significant difference between the offer price and the prevailing market price is a key factor for investors. The market price on BSE was ₹37.45 per share on June 23, 2026, over three times the offer price.
The backstory
The acquisition is driven by the acquirers' interest in the same line of business as Rekvina Laboratories. The strategic rationale includes integrating operations, products, and services to enhance market position and achieve operational efficiencies through shared resources.
What changes now
The IDC's opinion allows the open offer process to move forward. However, the stark contrast between the offer price and market price means shareholders need to make a critical decision. The IDC has advised public shareholders to conduct their own evaluation.
Risks to watch
The primary risk for shareholders is tendering shares at a price significantly below the market value. Investors need to assess if the offer provides any compelling advantages, which seems unlikely given the price disparity.
Peer comparison
No direct peer comparison is available in the filing regarding open offer scenarios. However, typically, open offers are made at or above the prevailing market price to attract shareholders. Rekvina's situation deviates from this norm.
Context metrics (time-bound)
- Open Offer Size: 28,90,100 Equity Shares
- Offer Price: ₹10 per share
- Total Consideration: ₹2.89 crore
- Market Price (June 23, 2026): ₹37.45 per share
What to track next
Investors should closely monitor the open offer timeline and make an informed decision based on their assessment of the company's future prospects versus the current market trading value.